OCT 16, 2015 08:56 AM PDT

A Cure for Ebola?

WRITTEN BY: Kerry Evans
This isn’t the first time I’ve written about Ebola (and it probably won’t be the last).  Recently, a number of techniques for quickly diagnosing Ebola have been developed, and could make it to market in the (hopefully near) future.  Until now, however, there has been little progress towards vaccines or therapeutics for the virus.  Researchers at the US Army Medical Research Institute of Infectious Diseases and Gilead Sciences isolated a compound called GS-5734 that cured monkeys of Ebola virus disease (EVD).  
 
GS-5734 is a promising Ebola therapeutic.

Ebola virus causes a devastating hemorrhagic fever in humans and non-human primates, where the average survival rate is about 50%.  Clinicals symptoms include fever, headaches, vomiting, and bleeding, both internal and external.  Death often results from low blood pressure and overall fluid loss.  

GS-5734 is a nucleotide analog that inhibits the viral RNA polymerase, but does not affect host polymerases (an important consideration).  The group first tested the ability of GS-5734 to inhibit Ebola virus replication in human cell culture.  Next, they treated one group of Ebola-infected monkeys with 3 mg/kg of GS-5734, but only 50% of them survived.  They treated a second set of monkeys with a higher dose of the drug, 10 mg/kg, and all of the monkeys survived.  Clinical symptoms of EVD such as excessive bleeding were also reduced.  Although viral load was significantly decreased, it does not appear that the monkeys were “cured” of the virus.

GS-5734 was also effective against other Filoviruses such as Marburg, indicating it could serve as a broad-spectrum anti-viral.  However, the fact that Ebola virus was still detectable in the “cured” monkeys leaves me only cautiously optimistic.      

Check out the following video for information on Ebola gene-silencing technology being developed in Canada by Tekmira.  
 

Sources: ID Week 2015, Medical News Today, Genome Web, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
OCT 23, 2019
Microbiology
OCT 23, 2019
Disruptions in the Infant Gut Microbiome Linked to Growth Delays
When the microbiome fails to develop properly, it can impair a child's ability to thrive....
OCT 23, 2019
Microbiology
OCT 23, 2019
Cigarette Smoke can Increase the Pathogenicity of Microbes
Strains of MRSA can become more resistant to antibiotics when exposed to cigarette smoke....
OCT 23, 2019
Cell & Molecular Biology
OCT 23, 2019
A New Type of Cellular Communication is Discovered
While in a group, individual spirostomum can make ultrafast contractions in a coordinated fashion, without using chemical signals or contact....
OCT 23, 2019
Genetics & Genomics
OCT 23, 2019
DNA Analysis Shows How Algae Respond to a Changing Environment
While a type of algae appears to be thriving in the face of its downgraded envrionment, the story is turning out to be more complex....
OCT 23, 2019
Neuroscience
OCT 23, 2019
Lab-grown mini brains make humanlike 'brain waves'
When a fetus reaches six months old, it starts to produce electrical signals resembling brain waves. Now, we know that clusters of lab-grown human brain ce...
OCT 23, 2019
Microbiology
OCT 23, 2019
Raising Awareness of Valley Fever
Valley fever primarily occurs in Arizona and California, and infects around 10,000 people every year....
Loading Comments...